Literature DB >> 2302060

Metastatic potential of colon carcinoma. Expression of ABO/Lewis-related antigens.

S D Hoff1, T Irimura, Y Matsushita, D M Ota, K R Cleary, S Hakomori.   

Abstract

Four monoclonal antibodies specific to various Lewisx-related antigens were tested for binding to monolayers and detergent extracts of the human colon carcinoma cell line HT-29 P and its metastatic variant HT-29 LMM. Only monoclonal antibody FH6 (antisialyl-dimeric Lex) bound more to the metastatic variant compared with HT-29 P. Detergent extracts of human tissues were then assayed for their FH6-binding activity. Normal colonic mucosa displayed less FH6 binding than either Dukes stage B or D primary colon carcinomas. Liver metastases from colorectal carcinoma demonstrated greater binding than stage B and stage D primary tumors, and more than normal liver. Expression of sialyl-dimeric Lex increases as the metastatic potential of colorectal carcinomas increases, and is related to the progression of colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2302060     DOI: 10.1001/archsurg.1990.01410140084013

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  15 in total

1.  Novel adapter protein AP162 connects a sialyl-Le(x)-positive mucin with an apoptotic signal transduction pathway.

Authors:  S Hartel-Schenk; A Gratchev; M L Hanski; D Ogorek; G Trendelenburg; M Hummel; M Höpfner; H Scherübl; M Zeitz; C Hanski
Journal:  Glycoconj J       Date:  2001 Nov-Dec       Impact factor: 2.916

2.  Classical Hodgkin's disease. Clinical impact of the immunophenotype.

Authors:  R von Wasielewski; M Mengel; R Fischer; M L Hansmann; K Hübner; J Franklin; H Tesch; U Paulus; M Werner; V Diehl; A Georgii
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

3.  Fucosyltransferase III and sialyl-Le(x) expression correlate in cultured colon carcinoma cells but not in colon carcinoma tissue.

Authors:  C Hanski; E Klussmann; J Wang; C Böhm; D Ogorek; M L Hanski; S Krüger-Krasagakes; J Eberle; A Schmitt-Gräff; E O Riecken
Journal:  Glycoconj J       Date:  1996-10       Impact factor: 2.916

4.  Alterative expression of the collagenase and adhesion molecules in the highly metastatic clones of human colonic cancer cell lines.

Authors:  Y Nakayama; K Okazaki; K Shibao; T Sako; K Hirata; N Nagata; M Kuwano; H Itoh
Journal:  Clin Exp Metastasis       Date:  1998-07       Impact factor: 5.150

5.  Inhibition of colon carcinoma cell lung colony formation by a soluble form of E-selectin.

Authors:  G Mannori; D Santoro; L Carter; C Corless; R M Nelson; M P Bevilacqua
Journal:  Am J Pathol       Date:  1997-07       Impact factor: 4.307

6.  Metastatic behavior and cell surface properties of HT-29 human colon carcinoma variant cells selected for their differential expression of sialyl-dimeric Le(x)-antigen.

Authors:  Y Matsushita; S D Hoff; E D Nudelman; M Otaka; S Hakomori; D M Ota; K R Cleary; T Irimura
Journal:  Clin Exp Metastasis       Date:  1991 May-Jun       Impact factor: 5.150

7.  Human lung adenocarcinoma cell lines with different lung colonization potential (LCP), and a correlation between expression of sialosyl dimeric Le(x) (defined by MAb FH6) and LCP.

Authors:  H Inufusa; N Kojima; M Yasutomi; S Hakomori
Journal:  Clin Exp Metastasis       Date:  1991 May-Jun       Impact factor: 5.150

8.  Cysteinyl leukotriene receptor antagonists inhibit tumor metastasis by inhibiting capillary permeability.

Authors:  Masako Nozaki; Masanobu Yoshikawa; Kunihiko Ishitani; Hiroyuki Kobayashi; Kiyohiro Houkin; Kohzoh Imai; Yoichiro Ito; Takamura Muraki
Journal:  Keio J Med       Date:  2010

9.  [Blood group antigen expression in papillary carcinoma of the thyroid gland. An immunohistochemical and clinical study of expression of Lewis, ABO and related antigens].

Authors:  A Larena; M Vierbuchen; S Schröder; A Larena-Avellaneda; I Hadshiew; R Fischer
Journal:  Langenbecks Arch Chir       Date:  1996

10.  Elevation of ratio of urinary N-acetylneuraminlactose to free sialic acid in some advanced cancer patients.

Authors:  I Shimada; M Shoji; R Futatsuya; T Katoh; Y Kominato; T Sakamoto; T Fujikura
Journal:  J Gastroenterol       Date:  1995-02       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.